RMD Financial Facts
Other, net (note 12): 1.27MCost of sales: 196.27M
See Full Income Statement
Total non-current liabilities: 929.14M
Long-term debt (note 10): 873.51M
See Full Balance Sheet
ResMed Inc. (RMD) Earnings
|
Expand Research on RMD
| Next EPS Date | 7/30/26 | EPS Growth Rate | +13.3% |
|---|---|---|---|
| Average EPS % Beat Rate | +2.2% | Revenue Growth Rate | +13.1% |
| Average % Move 1-Wk after EPS | +0.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
7/30/26  |
Q426 | N/A | $2.89 | N/A | N/A | $1.47B | N/A | N/A | N/A | ||
| 4/30/26 | Q326 | $2.86 | $2.81 | +$0.05 | $1.4B | $1.42B | N/A |  | | Details | |
| 1/29/26 | Q226 | $2.81 | $2.73 | +$0.08 | $1.4B | $1.4B | N/A | | | Details | |
| 10/30/25 | Q126 | $2.55 | $2.52 | +$0.03 | $1.3B | $1.33B | N/A | | | Details | |
| 7/31/25 | Q425 | $2.55 | $2.48 | +$0.07 | $1.3B | $1.33B | N/A | | | Details | |
| 4/23/25 | Q325 | $2.37 | $2.39 | -$0.02 | $1.3B | $1.29B | N/A | | | Details | |
| 1/30/25 | Q225 | $2.43 | $2.32 | +$0.11 | $1.28B | $1.27B | N/A | | | Details | |
| 10/24/24 | Q125 | $2.20 | $2.05 | +$0.15 | $1.22B | $1.19B | N/A | | | Details |
